MERRIMACK PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Four
MERRIMACK PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Four of $6.60 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2018-11-07
- 2018-09-30: Long-Term Debt, Maturity, Year Four $6.60M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2018-09-30 | $6.60M 10-Q · filed 2018-11-07 |